MARK Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
MARK2 Antikörper (B-1) | sc-365405 | mouse IgG1 κ | 416-501 (h) | WB, IP, IF, ELISA | h | 2 | ||
MARK3 Antikörper (F-6) | sc-376116 | mouse IgG1 κ | 447-501 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
MARK3 Antikörper (G-11) | sc-365461 | mouse IgG3 κ | 12-39 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
MARK3 Antikörper (G-7) | sc-376115 | mouse IgG2a κ | 447-501 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | neu |
MARK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
MARK1 CRISPR/Cas9 KO Plasmid (h) | sc-404508 | h | Gene Knockout | GFP | 0 | ||
MARK1 HDR Plasmid (h) | sc-404508-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MARK2 CRISPR/Cas9 KO Plasmid (h) | sc-403714 | h | Gene Knockout | GFP | 1 | ||
MARK2 HDR Plasmid (h) | sc-403714-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
MARK2 Double Nickase Plasmid (h) | sc-403714-NIC | h | Gene Knockout | Puromycin | 1 | ||
MARK2 Double Nickase Plasmid (h2) | sc-403714-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
MARK3 CRISPR/Cas9 KO Plasmid (h) | sc-406362 | h | Gene Knockout | GFP | 0 |
MARK CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
MARK4 CRISPR Activation Plasmid (h) | sc-404386-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 |
MARK siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
MARK1 siRNA (h) | sc-75749 | h | Gene Silencing | N/A | 0 | ||
MARK1 shRNA Plasmid (h) | sc-75749-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK1 shRNA (h) Lentivirale Partikel | sc-75749-V | h | Gene Silencing | Puromycin | 0 | ||
MARK1 siRNA (m) | sc-75750 | m | Gene Silencing | N/A | 0 | ||
MARK1 shRNA Plasmid (m) | sc-75750-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK1 shRNA (m) Lentivirale Partikel | sc-75750-V | m | Gene Silencing | Puromycin | 0 | ||
MARK2 siRNA (h) | sc-45793 | h | Gene Silencing | N/A | 0 | ||
MARK2 shRNA Plasmid (h) | sc-45793-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK2 shRNA (h) Lentivirale Partikel | sc-45793-V | h | Gene Silencing | Puromycin | 0 | ||
MARK2 siRNA (m) | sc-45794 | m | Gene Silencing | N/A | 0 | ||
MARK2 shRNA Plasmid (m) | sc-45794-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK2 shRNA (m) Lentivirale Partikel | sc-45794-V | m | Gene Silencing | Puromycin | 0 | ||
MARK3 siRNA (h) | sc-43649 | h | Gene Silencing | N/A | 0 | ||
MARK3 shRNA Plasmid (h) | sc-43649-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK3 shRNA (h) Lentivirale Partikel | sc-43649-V | h | Gene Silencing | Puromycin | 0 | ||
MARK3 siRNA (m) | sc-60087 | m | Gene Silencing | N/A | 0 | ||
MARK3 shRNA Plasmid (m) | sc-60087-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK3 shRNA (m) Lentivirale Partikel | sc-60087-V | m | Gene Silencing | Puromycin | 0 | ||
MARK4 siRNA (h) | sc-97671 | h | Gene Silencing | N/A | 0 | ||
MARK4 shRNA Plasmid (h) | sc-97671-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK4 shRNA (h) Lentivirale Partikel | sc-97671-V | h | Gene Silencing | Puromycin | 0 | ||
MARK4 siRNA (m) | sc-149275 | m | Gene Silencing | N/A | 0 | ||
MARK4 shRNA Plasmid (m) | sc-149275-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK4 shRNA (m) Lentivirale Partikel | sc-149275-V | m | Gene Silencing | Puromycin | 0 |